PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 310,000
+11,500 (3.85%)
Apr 16, 2026, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 3.22 trillion as of April 16, 2026. Its market cap has decreased by -2.97% in one year.
Market Cap
3.22T
Enterprise Value
2.85T
Revenue
536.29B
Ranking
n/a
PE Ratio
20.76
Stock Price
310,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.22T, an increase of 219.12%. That is a compound annual growth rate of 11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 3.10T | -25.93% |
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 8.33T |
| LigaChem Biosciences | 7.03T |
| Peptron | 6.25T |
| Voronoi | 5.32T |
| SK bioscience | 3.50T |
| D&D Pharmatech | 3.50T |
| OliX Pharmaceuticals | 3.36T |
| Hugel | 2.85T |